Latino communities make up about 14% of Oregon’s population, but are represented in only 5% of clinical trials at the OHSU Knight Cancer Institute.
PORTLAND, Oregon — Clinical trials are an important way for cancer patients to get help from promising, new therapies, but some people face obstacles taking part in them. A new program at Oregon Health and Science University (OHSU) is being developed to make clinical trials more inclusive.
Latino communities make up about 14% of Oregon’s population, but only 5% of cancer patients in interventional clinical trials in health care facilities across the state.
Dr. Eneida Nemecek is a professor at
→ Continue reading at KGW TV